Connor, Clark & Lunn Investment Management (CC&L)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.84M | Buy |
|
|||||
|
2022
Q3 | $6.72M | Buy |
|
|||||
|
2022
Q2 | $1.34M | Buy |
|
|||||
|
2022
Q1 | $297K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $6.18M | Buy |
|
|||||
|
2021
Q1 | $5.29M | Buy |
|
|||||
|
2020
Q4 | $2.98M | Buy |
|
|||||
|
2020
Q3 | $288K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $177K | Sell |
|
|||||
|
2017
Q3 | $257K | Buy |
|
|||||
|
2017
Q2 | $206K | Buy |
|
|||||
|
2017
Q1 | $188K | Buy |
|